Home

Decheng Capital Global Life Sciences Fund IV, L.P.

CIK 1834150 · last filed 2024-01-31

Decheng Capital Global Life Sciences Fund IV, L.P. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for CGON, was dated Jan 31, 2024. Across all open-market trades the lifetime net is +$38.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $358.8M across reported positions. The firm reports its address in Grand Cayman, E9. 6 SEC filings were submitted jointly with Xiangmin Cui.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$358.77M

Companies

1

Total Filings

1

Lifetime Open-Market Net

$38.00M

Filer Profile

Reported Address
C/O MAPLES CORPORATE SERVICES LIMITED
UGLAND HOUSE, P.O. BOX 309
GRAND CAYMAN, E9 KY1-1104
Phone
(345) 949-8066
State of Incorporation
Cayman Islands
Related Filers
Xiangmin Cui — 6 joint filings, latest 2025-02-19
Decheng Capital Global Healthcare Fund (Master), LP — 4 joint filings, latest 2025-02-19
Decheng Capital Global Healthcare GP, LLC — 4 joint filings, latest 2025-02-19
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CGON 10%+ Owner 4,958,812 $72.35 $358.77M $38.00M 1 2024-01-31

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-01-31 CGON Mixed +20,140,990 $38.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.